Medical Polymers Market Share, Size, Growth Opportunities, Outlook, Statistics, Market Scope, Revenue, Research, Trends Analysis & Global Industry Forecast Report, 2022-2029
Medical Polymers Market, By Product (Medical Resins & Fibres, Medical Elastomers, and Biodegradable Plastics), By Application (Medical Equipment & Devices, Medical Packaging, and Others), and By Region
1. Executive Summary
1.1. Key Market Insights
2. Introduction
2.1. Study Objectives
2.2. Market Definition
2.2.1. Market Covered
2.2.2. Regional Coverage
2.2.3. Study Years & Currency
2.3. Market Stakeholders
2.4. Key Questions this Study will Answer
2.5. GMI Research’s Approach & Methodology
2.5.1. Research Data
2.5.2. Primary Data
2.5.3. Demand Side and Supply Side Analysis
2.5.4. Market Size Estimation
2.5.5. Research Assumptions
3. Global Medical Polymers Market- Overview
3.1. Introduction
3.2. Market Segmentation
3.3. Value Chain Analysis
3.4. Market Drivers
3.5. Market Restraints
3.6. Market Trends
4. Global Medical Polymers Market Revenue Forecast till 2029
5. Global Medical Polymers Market by Product Revenue Forecast till 2029
5.1. Medical Resins & Fibres
5.1.1. Polyvinyl Chloride
5.1.2. Polypropylene
5.1.3. Polyethylene
5.1.4. Polystyrene
5.1.5. Others
5.2. Medical Elastomers
5.2.1. Styrene block co-polymer
5.2.2. Rubber latex
5.2.3. Others
5.3. Biodegradable Plastics
6. Global Medical Polymers Market by Application Revenue Forecast till 2029
6.1. Medical Equipment & Devices
6.2. Medical Packaging
6.3. Others
7. Global Medical Polymers Market by Region Forecast till 2029
7.1. North America Medical Polymers Market Revenue Forecast till 2029
(Option 1: As a part of the free 25% customization)
7.1.1. North America Medical Polymers Market by Product
7.1.1.1. Medical Resins & Fibres
7.1.1.1.1. Polyvinyl Chloride
7.1.1.1.2. Polypropylene
7.1.1.1.3. Polyethylene
7.1.1.1.4. Polystyrene
7.1.1.1.5. Others
7.1.1.2. Medical Elastomers
7.1.1.2.1. Styrene block co-polymer
7.1.1.2.2. Rubber latex
7.1.1.2.3. Others
7.1.1.3. Biodegradable Plastics
7.1.2. North America Medical Polymers Market by Application
7.1.2.1. Medical Equipment & Devices
7.1.2.2. Medical Packaging
7.1.2.3. Others
7.1.3. United States of America (US) Medical Polymers Market All-Up
7.1.4. Canada Medical Polymers Market All-Up
7.2. Europe Medical Polymers Market Revenue Forecast till 2029
(Option 2: As a part of the free 25% customization)
7.2.1. Europe Medical Polymers Market by Product
7.2.1.1. Medical Resins & Fibres
7.2.1.1.1. Polyvinyl Chloride
7.2.1.1.2. Polypropylene
7.2.1.1.3. Polyethylene
7.2.1.1.4. Polystyrene
7.2.1.1.5. Others
7.2.1.2. Medical Elastomers
7.2.1.2.1. Styrene block co-polymer
7.2.1.2.2. Rubber latex
7.2.1.2.3. Others
7.2.1.3. Biodegradable Plastics
7.2.2. Europe Medical Polymers Market by Application
7.2.2.1. Medical Equipment & Devices
7.2.2.2. Medical Packaging
7.2.2.3. Others
7.2.3. United Kingdom (UK) Medical Polymers Market All-Up
7.2.4. Germany Medical Polymers Market All-Up
7.2.5. France Medical Polymers Market All-Up
7.2.6. Spain Medical Polymers Market All-Up
7.2.7. Rest of Europe Medical Polymers Market All-Up
7.3. Asia-Pacific Medical Polymers Market Revenue Forecast till 2029
(Option 3: As a part of the free 25% customization)
7.3.1. Asia-Pacific Medical Polymers Market by Product
7.3.1.1. Medical Resins & Fibres
7.3.1.1.1. Polyvinyl Chloride
7.3.1.1.2. Polypropylene
7.3.1.1.3. Polyethylene
7.3.1.1.4. Polystyrene
7.3.1.1.5. Others
7.3.1.2. Medical Elastomers
7.3.1.2.1. Styrene block co-polymer
7.3.1.2.2. Rubber latex
7.3.1.2.3. Others
7.3.1.3. Biodegradable Plastics
7.3.2. Asia-Pacific Medical Polymers Market by Application
7.3.2.1. Medical Equipment & Devices
7.3.2.2. Medical Packaging
7.3.2.3. Others
7.3.3. China Medical Polymers Market All-Up
7.3.4. India Medical Polymers Market All-Up
7.3.5. Japan Medical Polymers Market All-Up
7.3.6. Rest of APAC Medical Polymers Market All-Up
7.4. RoW Medical Polymers Market Revenue Forecast till 2029
(Option 4: As a part of the free 25% customization)
7.4.1. RoW Medical Polymers Market by Product
7.4.1.1. Medical Resins & Fibres
7.4.1.1.1. Polyvinyl Chloride
7.4.1.1.2. Polypropylene
7.4.1.1.3. Polyethylene
7.4.1.1.4. Polystyrene
7.4.1.1.5. Others
7.4.1.2. Medical Elastomers
7.4.1.2.1. Styrene block co-polymer
7.4.1.2.2. Rubber latex
7.4.1.2.3. Others
7.4.1.3. Biodegradable Plastics
7.4.2. RoW Medical Polymers Market by Application
7.4.2.1. Medical Equipment & Devices
7.4.2.2. Medical Packaging
7.4.2.3. Others
7.4.3. Brazil Medical Polymers Market All-Up
7.4.4. South Africa Medical Polymers Market All-Up
7.4.5. Saudi Arabia Medical Polymers Market All-Up
7.4.6. UAE Medical Polymers Market All-Up
7.4.7. Rest of world (remaining countries of the LAMEA region) Medical Polymers Market All-Up
8. Competitive Landscape Analysis
8.1. Porter’s Five Forces Analysis
8.2. Industry – Competitive Landscape
8.3. Market Presence (Intensity Mapping)
8.4. Key Strategic Market Developments
9. Company Profiles (Option 5: Free 25% Customization - Profiles of 5 Additional Companies of your Choice)
9.1. Evonik Industries AG
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Footprint & Employee Strength
9.1.4. Product Offerings
9.1.5. Financials
9.1.6. Key Company Developments
9.2. Formosa Plastics Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Footprint & Employee Strength
9.2.4. Product Offerings
9.2.5. Financials
9.2.6. Key Company Developments
9.3. BASF SE
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Footprint & Employee Strength
9.3.4. Product Offerings
9.3.5. Financials
9.3.6. Key Company Developments
9.4. Celanese Corporation
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Footprint & Employee Strength
9.4.4. Product Offerings
9.4.5. Financials
9.4.6. Key Company Developments
9.5. Solvay
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Footprint & Employee Strength
9.5.4. Product Offerings
9.5.5. Financials
9.5.6. Key Company Developments
9.6. Covestro AG
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Footprint & Employee Strength
9.6.4. Product Offerings
9.6.5. Financials
9.6.6. Key Company Developments
9.7. Bayer AG
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Footprint & Employee Strength
9.7.4. Product Offerings
9.7.5. Financials
9.7.6. Key Company Developments
9.8. Koninklijke DSM N.V.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Footprint & Employee Strength
9.8.4. Product Offerings
9.8.5. Financials
9.8.6. Key Company Developments
9.9. Exxon Mobil Corporation
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Footprint & Employee Strength
9.9.4. Product Offerings
9.9.5. Financials
9.9.6. Key Company Developments
9.10. Dow, Inc.
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Footprint & Employee Strength
9.10.4. Product Offerings
9.10.5. Financials
9.10.6. Key Company Developments
10. About GMI Research
*Details on Financials might not be available in case of unlisted/private companies.
*The list of companies is based on preliminary research in this report, the companies in the final report may change based on research findings.a
- Published Date: Aug - 2021
- Report Format: Excel/PPT
- Report Code: UP2390-001001
Licensing Options
Single-User License:
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
The report is used by the purchaser (One Individual) only
Multi-User License:Report is shared with maximum 5 users (employees) including the purchaser of the purchasing corporation only
Corporate License:
Report is shared with unlimited user (employees) of the purchasing corporation only
Medical Polymers Market Share, Size, Growth Opportunities, Outlook, Statistics, Market Scope, Revenue, Research, Trends Analysis & Global Industry Forecast Report, 2022-2029
$ 4,499.00 – $ 6,649.00
Why GMI Research
